These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25119951)

  • 1. Knowing the previously unknown: identification of a methodological challenge for pharmacoepidemiology.
    Fischer MA
    Med Care; 2014 Sep; 52(9):767-9. PubMed ID: 25119951
    [No Abstract]   [Full Text] [Related]  

  • 2. Causal inference using mixture models: a word of caution.
    Robbins MW; Setodji CM
    Med Care; 2014 Sep; 52(9):770-2. PubMed ID: 25119952
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence of sample use among new users of statins: implications for pharmacoepidemiology.
    Li X; Stürmer T; Brookhart MA
    Med Care; 2014 Sep; 52(9):773-80. PubMed ID: 24984210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To switch (statins) or not to switch? That is the question.
    Athyros VG; Tziomalos K; Karagiannis A; Mikhailidis DP
    Expert Opin Pharmacother; 2010 Dec; 11(18):2943-6. PubMed ID: 20958109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Better outcomes with generic statins.
    Harv Heart Lett; 2014 Dec; 25(4):8. PubMed ID: 26094262
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of a generic rosuvastatin in a real-world setting: prospective, observational clinical study in Lebanese patients.
    Betto M; Fares J; Saliba N; Ballout H
    Ann Saudi Med; 2017; 37(5):366-374. PubMed ID: 28988251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-density lipoprotein cholesterol as the Holy Grail.
    Cannon CP
    JAMA; 2011 Nov; 306(19):2153-5. PubMed ID: 22089726
    [No Abstract]   [Full Text] [Related]  

  • 8. Cholesterol-lowering statin therapy to prevent atherosclerotic cardiovascular disease - is the new guideline based on best evidence?
    Canoy D
    Prev Med; 2014 Dec; 69():317-8. PubMed ID: 25158207
    [No Abstract]   [Full Text] [Related]  

  • 9. Measurement of statin exposure in the absence of information on prescribed doses.
    Romppainen T; Rikala M; Aarnio E; Korhonen MJ; Saastamoinen LK; Huupponen R
    Eur J Clin Pharmacol; 2014 Oct; 70(10):1275-6. PubMed ID: 25146693
    [No Abstract]   [Full Text] [Related]  

  • 10. High dose statin therapy for all patients with coronary artery disease?
    Knobler H
    Isr Med Assoc J; 2005 Nov; 7(11):736-8. PubMed ID: 16308999
    [No Abstract]   [Full Text] [Related]  

  • 11. Capsule commentary on Romanelli et al., predictors of statin compliance after switching from branded to generic agents among managed-care beneficiaries.
    Pathak H
    J Gen Intern Med; 2014 Oct; 29(10):1391. PubMed ID: 25103124
    [No Abstract]   [Full Text] [Related]  

  • 12. Sleight of hand in trial design: average behaviour is not average, not all new information is really new.
    Reynolds T
    Int J Clin Pract; 2009 Apr; 63(4):534-5. PubMed ID: 19335700
    [No Abstract]   [Full Text] [Related]  

  • 13. Ask the doctor. Taking a cholesterol-lowering statin has brought down my bad cholesterol (LDL) to only 37 mg/dL. My liver and muscles are fine. The very low LDL worries my doctor. Should I change my regimen?
    Lee TH
    Harv Heart Lett; 2002 Oct; 13(2):8. PubMed ID: 12393347
    [No Abstract]   [Full Text] [Related]  

  • 14. Generic atorvastatin is as effective as the brand-name drug (LIPITOR
    Loch A; Bewersdorf JP; Kofink D; Ismail D; Abidin IZ; Veriah RS
    BMC Res Notes; 2017 Jul; 10(1):291. PubMed ID: 28716156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary prevention for coronary heart disease in the United Kingdom, low-density lipoprotein cholesterol goals and statin switching-an expression of concern.
    Ray KK; Schofield PM
    Int J Clin Pract; 2007 Oct; 61(10):1608-11. PubMed ID: 17877646
    [No Abstract]   [Full Text] [Related]  

  • 16. Newer, lower, better? Lipid drugs and cardiovascular disease--the continuing story.
    Wierzbicki AS
    Int J Clin Pract; 2007 Jul; 61(7):1064-7. PubMed ID: 17577288
    [No Abstract]   [Full Text] [Related]  

  • 17. [Blocking the absorption of cholesterol in the treatment of hyperlipidemia--old and new ways of treatment].
    Vanhanen H
    Duodecim; 2004; 120(9):1105-10. PubMed ID: 15232853
    [No Abstract]   [Full Text] [Related]  

  • 18. The new strategy for statins: should you be taking one? Guidelines for taking cholesterol-lowering drugs now target overall risk rather than cholesterol values.
    Harv Heart Lett; 2014 Feb; 24(6):1, 7. PubMed ID: 24804341
    [No Abstract]   [Full Text] [Related]  

  • 19. Growing body of evidence shows benefits of aggressive lipid management in high-risk patients.
    Am J Manag Care; 2002 Jul; Suppl Symposium Reporter():3, 5. PubMed ID: 12608151
    [No Abstract]   [Full Text] [Related]  

  • 20. Low-density lipoprotein cholesterol-independent effects of statins on coronary artery disease.
    Takagi H; Umemoto T
    Am J Cardiol; 2011 Jan; 107(2):336. PubMed ID: 21211613
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.